3 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
Follow Stress: new trials by email Literature Review of Stress trials Research Report on Stress
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating the Protective Impact of LY-2940094 on Stress-induced Depression- and Anxiety-related Phenotypes in Humans Nociceptin Receptor Antagonist (LY-2940094), DS8R Biphasic Constant Current Stimulator - Depression - Major Depressive Disorder, Anxiety | Phase 2 | Withdrawn | Mclean Hospital | 2025-06-01 | 2025-09-25 | |
| Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use Placebo oral tablet, Yohimbine + Hydrocortisone, sham rTMS - Stress, Opioid-use Disorder | Phase 2 | Withdrawn | Wayne State University | 2023-04-10 | 2023-04-13 | |
| rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers yohimbine + hydrocortisone, medial prefrontal cortex rTMS, Placebo oral tablet - Stress, Healthy | Phase 2 | Withdrawn | Wayne State University | 2023-04-10 | 2023-04-13 |
Anxiety Disorders (1) · Opioid-Related Disorders (1)
Mental Disorders (2) · Chemically-Induced Disorders (1) · Narcotic-Related Disorders (1) · Substance-Related Disorders (1)
Hydrocortisone (2) · Yohimbine (2) · LY2940094 (1)
Wayne State University (2) · Mclean Hospital (1)
Manuel Kuhn, Ph.D. (1) · Mark Greenwald, PhD (1) · Mark K Greenwald, PhD (1)
P50MH119467 (1)